Proton pump inhibitor use increases risk of osteoporosis

10 Jun 2016


Published in the International Journal of Rheumatic Diseases, researchers from Iran found that PPI use is associated with an increased risk of developing osteoporosis.

Endocrinology Advisor


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story